NCT00006219View on ClinicalTrials.gov

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG

clarithromycin

DRUG

prasterone

Trial Locations (3)

32224

Mayo Clinic in Florida, Jacksonville

55905

Mayo Clinic, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER